3. Introduction6
Inborn errors of metabolism are group of genetically determined
biochemical disorder in which inherited defect in a single specific enzyme
that results in disruption or abnormality in a specific metabolic pathway
• Single gene defects
• Mostly autosomal recessive(exepct hunter’s,fabry’s,lesch-nyhan)
17/12/2014 3
4. Epidemiology
• According to a study in British Columbia, the overall incidence is approximately 40 cases
per 100,000 live births .
• Approximately 24 children per 100,000 births have a disease involving amino acids (e.g.
PKU), organic acids, primary lactic acidosis, galactosemia, or a urea cycle disease.
• Approximately 2.3 children per 100,000 births have some form of glycogen storage
disease.
• Approximately 8cases per 100,000 births (1 in 12,500) have a lysosomal storage disease;
• Approximately 3cases per 100 000 births have a respiratory chain-based mitochondrial
disease and 3 to 4 cases per 100 000 of births have a peroxisomal disorder.
17/12/2014 4
5. Epidemiology cont…,
• Mortality/Morbidity
Asymptomatic with slow degeneration over decades can be life-threatening
over hours
Episodic with intermittent decompensations
• Race
Incidence varies with different race and ethnic groups
Incidence of Cystic fibrosis,1/1600people of European descent
Incidence of Sickle cell anemia,1/600people of African descent
Incidence of Tay-Sachs,1/3500people of Ashkenazi Jews
• Sex
Male-to-female ratio 1:1 for autosomal recessive transmission and X-linked
recessive transmission.
• Age
Presenting at birth- phenylketonuria
Or later life -diabetes mellitus
17/12/2014 5
6. Pathophysiology
Gene mutations or gene deletions of ,,,,
DNA Enzyme
which code for a Receptor
Transport vehicle
Membrane pump
Structural element
Single gene defects result in abnormalities in the synthesis or catabolism of
Proteins, carbohydrates, fats or complex molecules.
Defect in an enzyme or transport protein, which results in block in a pathway.
Effects are due to toxic accumulations of substances .
17/12/2014 6
11. Glycogen Storage Diseases4
Disorder Enzyme Defect Organ(s)involved Characteristic Features
Von Gierke’s disease
Type I***
Glucose 6-phosphatase Liver, kidney, Intestine Glycogen accumulates in hepatocytes &
renal cells, enlarged liver & kidney,
fasting hypoglycemia,lactic acidemia,
hyperlipidemia,ketosis,gouty arthritis
Pompe’s disease
Type II***
Lysosomal α-1,4-glucosidase All organs Glycogen accumulates in lysosomes in
allmost all the tissues;enlarged heart
&liver, nervous system also affected,
death occurs at earlier age due to heart
failure
Cori’s
Type III
Amylo α-1,6-glucosidase Liver,muscle,heart,
leukocytes
Branched chain glycogen accumulates,
liver enlarged
Anderson’s disease
Type IV
Glucosyl 4,6-transferase Most tissues A rare disease, glycogen with only few
branches accumulates,liver cirrhosis
McArdle’s disease
Type V***
Muscle glycogen phosphorylase Skeletal muscle Very high muscle glycogen stores,
muscle cramps, muscle damage
Her’s disease
Type VI
Liver glycogen phosphorylase liver Enlarged liver,hypoglycemia,
ketoacidosis
Tarui’s disese
Type VII
phosphofructokinase Skeletal muscle, erythrocytes Muscle cramps,hemolysis
17/12/2014 11
12. Von Gierkes Disease Type I2
Clinical Manifestations
Constant hunger
Easy bruising & nose bleeds
Fatigue
Puffy cheeks
Thin chest
Glycogen deposits in Hepatocytes
17/12/2014 12
25. Albinism6
Clinical Manifestations
Absence of color in the hair, skin, or iris of the eye
Lighter than normal skin and hair
Patchy missing skin color
Crossed eyes
Light sensitivity
Rapid eye movements
Vision problems
17/12/2014 25
26. III. Sulfur Amino acids5
(methionine, cysteine, cystine)
Disorders Enzyme defect
Cystinuria Defect in renal reabsorption
Cystinosis Impairment in cystine utilization
Homocystinuria type I*** Cystathionine synthetase
Homocystinuria type II N 5, N10-Methylene THF reductase
Homocystinuria type III N 5-Methyl THF- homoscysteine
methyltransferase
Cystathionuria Cystathioninase
17/12/2014 26
52. When to suspect an IEM?6
Every child with unexplained ….
-neurological detoriation
Metabolic acidosis
Hypoglycemia
Inappropriate ketosis
Hypotonia
Cardiomyopathy
Hepatocellular dysfunction
Failure to thrive
Abnormal hair
Odour
…should suspected of having a metabolic disorder
17/12/2014 52
53. Neonatal Clinical Manifestations of IEMs6
Neurologic Signs:
Poor suck
Lethargy (progressive to coma)
Abnormalities of tone
Loss of reflexes
Seizures
Gastrointestinal Signs:
Poor feeding
Vomitting
Diarrhea
Respiratory Signs
Hyperpnea
Respiratory failure:
Organomegaly
Liver
Heart
17/12/2014 53
55. Common Screening Tests6
• Ferric chloride test
• Ninhydrin paper chromatography
• Quantitative measurement of amino acids in plasma and urine
• Ninhydrin post column liquid ion-exchange chromatography
• Urine organic acid analysis by Gas chromatography-mass spectrometry
• Plasma acylcarnitines analysis by mass spectrometry
• Urine purines and pyrimidines analysis by gas chromatography
• Tissue biopsy or necropsy; liver, muscle, brain, bone marrow. Skin biopsy and
fibroblast cultivation for specific enzyme testing
• Specific DNA testing
17/12/2014 55
56. Diagnosis6
• IEM can be detected in fetus in utero by the examination of blood cells obtained by
amniocentesis and fetoscopy
• New born screening ( must do on all infants in NICU)
PKU
Hemoglobinopathies
MSUD
• Laboratory tests after birth show higher than normal levels of particular metabolites in
the blood and urine
The values are higher in homozygous than in heterozygous carriers
Signs of various defects are usually seen only homozygous carriers
17/12/2014 56
58. Management6
• Dietary restriction
• Removal of food in the diet containing the non-degradable metabolite prevent
its accumulation . In those cases of IEM in which the non-degradable
metabolite is endogenous no treatment is available.
• Dietary supplementation or replacement
• Vitamins
• Intermediary metabolites, compounds or drugs that facilitate or retard specific
metabolic pathways
• Dialysis
• Enzyme replacement
• Gene therapy
• Bone marrow or organ transplantation
• Treatment of symptoms and complications
• Prenatal diagnosis and avoidance of pregnancy or abortion of an affected fetus
17/12/2014 58
59. Treatment of Acutely-Sick Child6
General therapy:
• Maintain vital functions
• Oxygenation
• Hydration
• Acid/base balance
Specific therapy:
• Treat infection
• High dose I.V glucose
• Carnitine supplementation
TO IDENTIFY PRIMARY METABOLIC DISORDER
17/12/2014 59
60. Therapeutic Measures of IEMs6
• D/C oral intake temporarily
• IVF’s with glucose to give 12-15 mg/kg/min glucose and atleast 60 kcal/kg to
prevent catabolism(may worsen PDH)
• Bicarbonate/citrate carnitine/glycine
• Na benzoate/arginine /citrulline
• Dialysis-not exchange transfusion
• Vitamins-often given in cocktails before dx is known
-biotin, B6, B12, riboflavin, thiamine, folate
17/12/2014 60
61. Treatment of Genetic Diseases6
• Modify environment e.g., diet , drugs
• Surgical ,correct or repair defect or organ transplantation
• Modify or replace defective gene product, mega dose vitamin therapy or enzyme
replacement
• Replace defective gene
• Correct altered DNA in defective gene
17/12/2014 61
62. References
• Robbin’s Basic Pathology, Kumar, Abbas, Aster; IXth Edition, pg 218 – 234
• W.A.D. Anderson’s Pathology Vth Edition Chap 31, pg 1041
• Anderson’s Pathology VIIIth Edition chap 3, pg 101 - 104
• Fundamentals of Biochemistry, A.C. Deb
• Text book of Biochemistry, U. Sathyanarayana, U.Chakrapani; Chap 13, 15
• Net resources
17/12/2014 62